Ayala Pharmaceuticals Inc (ADXS)

[polaco3us]

I am going to paste some of your statements so as to avoid confusión.
You said in your post:

The Ph 3 trial we have going is rather small. Other drugs that scored well have been rejected on the basis of size alone.

And there is no solid assurance that we can pass a Ph3 trial acceptable to the FDA...Many drugs look good till the Ph3 results face FDA approval


So for the first part, the trial size, please next time read up about the SPA process and purpose, and you will understand that your statement is FALSE.

The second statement is true, however this is true for every Biotech seeking approval.
So on ADXS case all depends on results because the SPA takes care of all the potential issues with the trial design.

Go Zen
Cheers

and please lets not spread lies and half truths on the board .. there are many newbies that fall for this ...